• What is Amedica Corporation's ticker symbol and on what exchange does it trade?
  • Amedica Corporation trades on the Nasdaq Capital Market under the ticker symbol "AMDA."

  • When did Amedica Corporation go public?
  • Amedica Corporation’s common stock began trading on the Nasdaq Capital Market on February 12, 2014. 

  • How can I buy Amedica Corporation's stock?
  • You may purchase Amedica Corporation’s stock through a registered stockbroker.

  • When were Amedica's stock splits?
  • Since the Company’s IPO on February 11, 2014, there have been no stock splits.

  • What is Amedica Corporation's dividend policy?
  • Amedica Corporation does not anticipate declaring any cash dividends to holders of its common stock in the foreseeable future.

  • Does Amedica Corporation have a direct stock purchase plan?
  • Amedica Corporation does not anticipate having a direct stock purchase plan in the foreseeable future.

  • When was Amedica Corporation incorporated?
  • Amedica Corporation was incorporated as “Amedica Corp.” in Delaware in 1996 and has since changed the name to Amedica Corporation.

  • Where is Amedica's corporate headquarters?
  • 1885 West 2100 South
    Salt Lake City, UT 84119

  • What is Amedica Corporation's CUSIP number?
  • Amedica Corporation’s CUSIP number is 023435 100

  • When do Amedica Corporation's fiscal quarters end?
  • First Quarter: March 31
    Second Quarter: June 30
    Third Quarter: September 30
    Fourth Quarter: December 31

  • Who should I contact with questions about my stock ownership?
  • Beneficial stockholders with shares held by a broker in the name of the brokerage house should contact their broker on all administrative matters.  If you are a registered stockholder and have questions regarding your account status (e.g. number of shares, missing certificates, address changes, etc.), please contact Amedica Corporation’s transfer agent.

  • Who is Amedica's transfer agent?
  • American Stock Transfer & Trust Company, LLC
    6201 15th Avenue
    Brooklyn, NY 11219
    T: 718-921-8124

  • Whom should I contact regarding investor inquiries?
  • Mike Houston 
    VP, Commercialization